Text Mining And Machine Reading: The Answer To Pharma's R&D Data Mountain?

Technology is expected to revolutionize parts of the life science industry, and slowly but surely pharma is embracing digital features in different aspects of its operating models – with clinical trials and disease management being the most popular starting points. But can technology prevent drug developers' early-stage pipelines from drying out?

As industry's "big data" buzz has intensified over the last few years, programs for "data mining," "machine reading," and "machine learning" have become increasingly popular.